J Surrallés Selected Research

Neoplasms (Cancer)

1/2022	Fanconi-like anemia related to a FANCM mutation.
11/2002	The Fanconi anaemia genome stability and tumour suppressor network.
8/2002	The clastogenic response of the 1q12 heterochromatic region to DNA cross-linking agents is independent of the Fanconi anaemia pathway.
8/2000	Multicolour FISH detection of radioactive iodine-induced 17cen-p53 chromosomal breakage in buccal cells from therapeutically exposed patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Surrallés Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 08/2000
3	Chromosome Breakage 08/2002 - 08/2000
3	Chromosome Aberrations (Chromosome Abnormalities) 09/2000 - 08/2000
2	Thyroid Neoplasms (Thyroid Cancer) 08/2000 - 08/2000
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Pancytopenia 11/2002
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2002
1	Chromosomal Instability (Chromosome Stability) 11/2002
1	Chromosome Fragility 08/2002
1	Carcinogenesis 08/2000
1	Hyperthyroidism 08/2000

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2002
2	IodineIBA 08/2000 - 08/2000
1	Proteins (Proteins, Gene)FDA Link 11/2002
1	diepoxybutaneIBA 08/2002
1	ChromatinIBA 08/2002
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2002
1	EuchromatinIBA 09/2000
1	HeterochromatinIBA 09/2000
1	Radioisotopes (Radionuclides)IBA 08/2000

Therapy/Procedure

2	Aftercare (After-Treatment) 08/2002 - 08/2000
1	Drug Tapering 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 01/2022
1	Thyroidectomy 08/2000